+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Benign prostatic hyperplasia (BPH) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Benign prostatic hyperplasia (BPH) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Prostate Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Prostate Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Castration-Sensitive Prostate Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Metastatic Castration-Sensitive Prostate Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Castrate-Resistant Prostate Cancer (CRPC)- Epidemiology Forecast to 2032 - Product Thumbnail Image

Castrate-Resistant Prostate Cancer (CRPC)- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Castrate-Sensitive Prostate Cancer (CSPC)- Epidemiology Forecast to 2032 - Product Thumbnail Image

Castrate-Sensitive Prostate Cancer (CSPC)- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Prostate cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Prostate cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Erleada - Drug Insight, 2019 - Product Thumbnail Image

Erleada - Drug Insight, 2019

  • Report
  • July 2019
  • Global
From
Prostate Cancer Diagnostics and Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Prostate Cancer Diagnostics and Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 124 Pages
  • Global
From
Japan Prostate Cancer Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Prostate Cancer Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 82 Pages
  • Japan
From
Benign Prostatic Hyperplasia Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Benign Prostatic Hyperplasia Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 183 Pages
  • Global
From
Benign Prostatic Hyperplasia (BPH) Treatment Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Benign Prostatic Hyperplasia (BPH) Treatment Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 172 Pages
  • Global
From
United Kingdom Prostate Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028 - Product Thumbnail Image

United Kingdom Prostate Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • October 2023
  • 81 Pages
  • United Kingdom
From
Prostate Cancer Therapeutics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Treatment (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, Others), By End User - Product Thumbnail Image

Prostate Cancer Therapeutics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Treatment (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, Others), By End User

  • Report
  • March 2023
  • 111 Pages
  • Global
From
Leuprolide Acetate Market 2022-2026 - Product Thumbnail Image

Leuprolide Acetate Market 2022-2026

  • Report
  • December 2021
  • 120 Pages
  • Global
From
Asia Pacific Prostate Cancer Nuclear Medicine Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type, PET Product, and End User - Product Thumbnail Image

Asia Pacific Prostate Cancer Nuclear Medicine Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type, PET Product, and End User

  • Report
  • August 2022
  • 120 Pages
  • Asia Pacific
From
Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, PET Product, and End User - Product Thumbnail Image

Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, PET Product, and End User

  • Report
  • May 2022
  • 180 Pages
  • Global
From
Castrate-Resistant Prostate Cancer Market Report and Forecast 2024-2032 - Product Thumbnail Image

Castrate-Resistant Prostate Cancer Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 200 Pages
  • Global
From
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more